For instance, though the familial breast cancer susceptibility gene 1 (BRCA1) mutations contributes to 5–10% of EOC, promoter hypermethylation of non-mutated BRCA1 allele is the second disruptive event to the development of this cancer (Barton et al., 2008). The gene discussed is BRCA1; the disease is cancer.